← Back to Search

Behavioral Intervention

Community Empowerment for Mental Health (COPE Trial)

N/A
Recruiting
Led By Jennifer L Scott, PhD, LCSW
Research Sponsored by Louisiana State University and A&M College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up t1 (pre-intervention), t2 (1 month post-intervention), t3 (2 months post-intervention), t4 (3 months post-intervention)
Awards & highlights

COPE Trial Summary

This trial examines if the COPE intervention can help adults in disaster-affected communities with mental health, coping, social support and community resilience.

Who is the study for?
This trial is for adults over 18 who are staff or members of Together Baton Rouge. It's aimed at those involved in or affected by recent disasters, focusing on improving mental health and resilience.Check my eligibility
What is being tested?
The COPE intervention, which includes three sessions designed to enhance mental well-being, coping skills, social support, and community resilience after a disaster. Its effectiveness will be compared with standard house meetings.See study design
What are the potential side effects?
Since COPE is a psychosocial intervention rather than a medical treatment, it may not have typical 'side effects,' but participants might experience emotional discomfort discussing stressful experiences.

COPE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~t1 (pre-intervention), t2 (1 month post-intervention), t3 (2 months post-intervention), t4 (3 months post-intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and t1 (pre-intervention), t2 (1 month post-intervention), t3 (2 months post-intervention), t4 (3 months post-intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in anxiety symptoms from baseline
Change in community resilience from baseline
Change in coping from baseline
+4 more
Secondary outcome measures
Intervention acceptibility
Intervention appropriateness
Intervention feasibility
Other outcome measures
Focus groups
Intervention fidelity
Interviews

COPE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: COPE InterventionExperimental Treatment1 Intervention
Is a three session brief group psychoeducational intervention. Session 1 is 4 hours, Session 2 and 3 are 1.5 hours. It is delivered in groups of 8-15 people with sessions spaced 1 month apart.
Group II: House Meeting ControlActive Control1 Intervention
Is a 1.5 hour group meeting delivered in groups of 8-15 people spaced 1 month apart.

Find a Location

Who is running the clinical trial?

Louisiana State University and A&M CollegeLead Sponsor
9 Previous Clinical Trials
719 Total Patients Enrolled
National Academies of Sciences, Engineering and MedicineUNKNOWN
University of Illinois at Urbana-ChampaignOTHER
189 Previous Clinical Trials
37,085 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there any availability to join this experiment as a participant?

"Based on the available data, this medical trial is still actively recruiting patients. It was first listed on March 25th 2023 and the most recent update to its listing took place October 17th 2023."

Answered by AI

How many individuals are being recruited to participate in this experiment?

"Affirmative. According to the data on clinicaltrials.gov, enrolment is presently open for this medical trial which was initially submitted in March of 2023 with its latest update occurring October 17th of that same year. 300 participants are required from a single research site."

Answered by AI
~150 spots leftby Jun 2025